Full Text of HR0163 103rd General Assembly
HR0163 103RD GENERAL ASSEMBLY |
| | HR0163 | | LRB103 31459 MST 59200 r |
|
| 1 | | HOUSE RESOLUTION
| 2 | | WHEREAS, Respiratory Syncytial Virus disease (RSV) is a | 3 | | highly transmissible, seasonal virus that can have severe and | 4 | | unpredictable outcomes for infants, including hospitalization; | 5 | | and
| 6 | | WHEREAS, Nearly all children will be infected with RSV by | 7 | | age two, and most infants requiring hospitalization were | 8 | | previously healthy and born at term; and
| 9 | | WHEREAS, RSV is the leading cause of hospitalization among | 10 | | infants in the U.S.; and
| 11 | | WHEREAS, RSV is the most common cause of bronchiolitis | 12 | | (inflammation of the small airways in the lung) and pneumonia | 13 | | (infection of the lungs) in children younger than one year of | 14 | | age in the U.S.; and | 15 | | WHEREAS, The current RSV season has resulted in | 16 | | significant morbidity and increased mortality; and | 17 | | WHEREAS, In the U.S., RSV infections typically occur | 18 | | during late fall, winter, and early spring, which means urgent | 19 | | preparation is needed; and |
| | | HR0163 | - 2 - | LRB103 31459 MST 59200 r |
|
| 1 | | WHEREAS, Monoclonal antibodies show promise in | 2 | | preventative protection against RSV; and | 3 | | WHEREAS, RSV disproportionally affects infants with | 4 | | Medicaid coverage, Native Americans, and Alaskan Natives; and
| 5 | | WHEREAS, The Vaccines For Children (VFC) program is a | 6 | | federally-funded program that provides vaccines at no cost to | 7 | | children who might not otherwise be vaccinated because of | 8 | | inability to pay; and
| 9 | | WHEREAS, VFC coverage is critical to ensure equity and | 10 | | access for all infants in order to have the greatest impact on | 11 | | disease burden; therefore, be it
| 12 | | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE | 13 | | HUNDRED THIRD GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | 14 | | we urge the Centers for Disease Control and Prevention to | 15 | | include new RSV immunization technologies (including vaccines | 16 | | and monoclonal antibodies), within the federal VFC program if | 17 | | the Advisory Committee on Immunization Practices of the | 18 | | Centers for Disease Control and Prevention issues | 19 | | administrative recommendations that are subsequently approved | 20 | | by the Director of the Centers for Disease Control and | 21 | | Prevention; and be it further
|
| | | HR0163 | - 3 - | LRB103 31459 MST 59200 r |
|
| 1 | | RESOLVED, That suitable copies of this resolution be | 2 | | delivered to Director of the Centers for Disease Control and | 3 | | Prevention Rochelle Walensky, Administrator of the Centers for | 4 | | Medicare and Medicaid Services (CMS) Chiquita Brooks-LaSure, | 5 | | and Secretary of the Department of Health and Human Services | 6 | | Xavier Becerra.
|
|